Which medications are FDA approved for the treatment of basal cell carcinoma (BCC)?

Updated: Mar 23, 2021
  • Author: Robert S Bader, MD; Chief Editor: William D James, MD  more...
  • Print

Oral agents approved by the FDA for advanced forms of BCC include the following Hedgehog pathway inhibitors (HHIs):

The checkpoint inhibitor cemiplimab (Libtayo) is approved for patients with locally advanced BCC and has been granted accelerated approval for metastatic BCC previously treated with an HHI or for whom an HHI is not appropriate.

See Treatment and Medication for more detail.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!